ArticlebioRxiv : the preprint server for biology2024

Anti-HIV-1 HSPC-based gene therapy with safety kill switch to defend against and attack HIV-1 infection.

Qi Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.